GeneDx (WGS) Insider Trading & Ownership $95.83 -5.75 (-5.66%) Closing price 04:00 PM EasternExtended Trading$92.92 -2.91 (-3.04%) As of 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends GeneDx (NASDAQ:WGS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage27.30%Number OfInsiders Buying(Last 12 Months)5Amount OfInsider Buying(Last 12 Months)$4.12 MNumber OfInsiders Selling(Last 12 Months)20Amount OfInsider Selling(Last 12 Months)$117.88 M Get WGS Insider Trade Alerts Want to know when executives and insiders are buying or selling GeneDx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address WGS Insider Buying and Selling by Quarter GeneDx Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/29/2025Katherine StuelandCEOSell1,657$78.48$130,041.36 1/29/2025Kevin FeeleyCFOSell275$78.48$21,582.00 1/7/2025Katherine StuelandCEOSell51,420$94.48$4,858,161.60 1/7/2025Kevin FeeleyCFOSell35,506$93.82$3,331,172.92 1/2/2025Katherine StuelandCEOSell18,006$78.18$1,407,709.08 1/2/2025Kevin FeeleyCFOSell1,430$76.04$108,737.20 12/16/2024Katherine StuelandCEOSell10,501$76.75$805,951.75 12/16/2024Kevin FeeleyCFOSell3,728$76.75$286,124.00 12/9/2024Katherine StuelandCEOSell3,661$76.37$279,590.57 12/9/2024Kevin FeeleyCFOSell1,137$76.37$86,832.69 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/2/2024Kevin FeeleyCFOSell263$78.39$20,616.57 11/21/2024Kevin FeeleyCFOSell12,019$73.76$886,521.44 11/19/2024Jason RyanDirectorSell31,510$71.28$2,246,032.80 11/18/2024Katherine StuelandCEOSell22,307$70.34$1,569,074.38 11/18/2024School Of Medicine At Mo IcahnMajor ShareholderSell126,782$70.78$8,973,629.96 11/15/2024Katherine StuelandCEOSell23,108$70.48$1,628,651.84 11/15/2024School Of Medicine At Mo IcahnMajor ShareholderSell20,359$69.78$1,420,651.02 10/31/2024School Of Medicine At Mo IcahnMajor ShareholderSell865,800$75.00$64,935,000.00 10/29/2024Katherine StuelandCEOSell2,154$66.60$143,456.40 10/29/2024Kevin FeeleyCFOSell274$66.60$18,248.40 9/9/2024Katherine StuelandCEOSell3,639$33.33$121,287.87 9/9/2024Kevin FeeleyCFOSell895$33.33$29,830.35 9/3/2024Kevin FeeleyCFOSell262$31.71$8,308.02 8/19/2024Opko Health, Inc.Major ShareholderSell50,000$34.49$1,724,500.00 8/15/2024Opko Health, Inc.Major ShareholderSell39,824$33.08$1,317,377.92 8/12/2024Opko Health, Inc.Major ShareholderSell59,787$33.95$2,029,768.65 8/8/2024Opko Health, Inc.Major ShareholderSell100,000$31.82$3,182,000.00 8/6/2024Opko Health, Inc.Major ShareholderSell12,994$29.35$381,373.90 7/31/2024Opko Health, Inc.Major ShareholderSell88,839$33.50$2,976,106.50 7/29/2024Katherine StuelandCEOSell2,154$33.54$72,245.16 7/29/2024Kevin FeeleyCFOSell274$33.54$9,189.96 7/29/2024Opko Health, Inc.Major ShareholderSell50,000$33.86$1,693,000.00 7/26/2024Opko Health, Inc.Major ShareholderSell60,000$33.85$2,031,000.00 7/24/2024Opko Health, Inc.Major ShareholderSell75,000$33.72$2,529,000.00 7/22/2024Opko Health, Inc.Major ShareholderSell50,000$32.61$1,630,500.00 7/19/2024Opko Health, Inc.Major ShareholderSell25,000$32.29$807,250.00 7/17/2024Opko Health, Inc.Major ShareholderSell25,000$32.93$823,250.00 7/5/2024Opko Health, Inc.Major ShareholderSell36,118$28.24$1,019,972.32 7/3/2024Opko Health, Inc.Major ShareholderSell14,082$28.23$397,534.86 7/1/2024Opko Health, Inc.Major ShareholderSell50,000$26.63$1,331,500.00 9/9 on TSLA from June to January (Ad)Please take a look at THIS case study on Target (TGT) You’ll see exactly how the tool works to trade long and short, even when the markets seem to be predicting the exact opposite. Now, this tool has been so accurate over recent months that I’m planning to send you 14 more real-world examples of winning trades that anyone using this tool could have captured. And it’s all building to Monday, February 24 @ 1pm ET when I’ll bring the tool to the public for the first time and show you how you can put it on your own charts!Tap here to catch the TGT case study and learn more6/17/2024Katherine StuelandCEOSell7,683$28.31$217,505.73 6/17/2024Kevin FeeleyCFOSell2,646$28.31$74,908.26 6/10/2024Katherine StuelandCEOSell2,652$24.92$66,087.84 6/10/2024Kevin FeeleyCFOSell895$24.92$22,303.40 6/3/2024Casdin Capital, LlcDirectorBuy100,000$20.82$2,082,000.00 5/28/2024Casdin Capital, LlcDirectorBuy18,304$20.61$377,245.44 5/23/2024Casdin Capital, LlcDirectorBuy7,500$19.59$146,925.00 5/13/2024Casdin Capital, LlcDirectorBuy50,000$23.31$1,165,500.00 4/29/2024Katherine StuelandCEOSell6,325$11.04$69,828.00 4/29/2024Kevin FeeleyCFOSell1,104$11.04$12,188.16 3/18/2024Kareem SaadInsiderSell2,008$10.59$21,264.72 3/18/2024Katherine StuelandCEOSell8,559$10.59$90,639.81 3/18/2024Kevin FeeleyCFOSell3,253$10.59$34,449.27 3/4/2024Casdin Capital, LlcDirectorBuy40,000$8.74$349,600.00 (Data available from 1/1/2013 forward) WGS Insider Trading Activity - Frequently Asked Questions Who is on GeneDx's Insider Roster? The list of insiders at GeneDx includes Anthony Prentice, Casdin Capital, Llc, Daniel Emmett Clark, Eric Schadt, Isaac Ro, Jason Ryan, Kareem Saad, Karen Ann White, Katherine Stueland, Keith A Meister, Kevin Feeley, Opko Health, Inc., Richard C Pfenniger Jr, Richard Miao, School Of Medicine At Mo Icahn, Shawn Assad, and Tactical Opportunit Blackstone. Learn more on insiders at WGS. What percentage of GeneDx stock is owned by insiders? 27.30% of GeneDx stock is owned by insiders. Learn more on WGS's insider holdings. Which GeneDx insiders have been buying company stock? The following insiders have purchased WGS shares in the last 24 months: Casdin Capital, Llc ($4,121,270.44), Jason Ryan ($72,062.34), and Richard C Pfenniger Jr ($69,900.00). How much insider buying is happening at GeneDx? Insiders have purchased a total of 292,546 WGS shares in the last 24 months for a total of $4,263,232.78 bought. Which GeneDx insiders have been selling company stock? The following insiders have sold WGS shares in the last 24 months: Jason Ryan ($2,246,166.78), Kareem Saad ($40,107.60), Karen Ann White ($28,926.46), Katherine Stueland ($11,700,554.62), Kevin Feeley ($5,021,118.59), Opko Health, Inc. ($23,874,134.15), and School Of Medicine At Mo Icahn ($75,329,280.98). How much insider selling is happening at GeneDx? Insiders have sold a total of 2,080,334 GeneDx shares in the last 24 months for a total of $118,240,289.18 sold. GeneDx Key ExecutivesMs. Katherine A. Stueland (Age 48)President, CEO & Director Compensation: $745.91k9 recent tradesMr. Kevin Feeley (Age 43)Chief Financial Officer Compensation: $488.19k10 recent tradesMs. Karen PonchnerSenior VP & Head of OperationsMr. Eric Olivares Ph.D.Chief Product & Technology OfficerMr. Devin K. Schaffer J.D.M.B.A., General CounselMr. Paul Kruszka M.D.Chief Medical OfficerMs. Melanie DuquetteChief Growth OfficerSabrina DunbarChief of Staff More Insider Trading Tools from MarketBeat Related Companies GH Insider Buying OPCH Insider Buying RDNT Insider Buying BTSG Insider Buying SHC Insider Buying SGRY Insider Buying VCYT Insider Buying LFST Insider Buying PRVA Insider Buying TDOC Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:WGS) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeneDx Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share GeneDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free WGS Stock Alerts